X0306 4 2023-03-06 0 0000818686 TEVA PHARMACEUTICAL INDUSTRIES LTD TEVA 0001722360 Stark David Matthew C/O TEVA PHARMACEUTICAL INDUSTRIES LTD. 124 DVORA HANEVI'A ST., TEL AVIV L3 6944020 ISRAEL 0 1 0 0 Exec. VP Chief Legal Officer Ordinary Shares 2023-03-06 4 S 0 16491 9.9309 D 52449.39 D Ordinary Shares 2023-03-07 4 S 0 49475 9.4279 D 2974.39 D The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.86 to $10.045, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.37 to $9.725, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price. /s/ Dov Bergwerk as attorney-in-fact for David M. Stark 2023-03-08